Drugs Classes Manufacturers Shortages Markets News

Pillstats aggregates public data: openFDA NDC Directory · CMS NADAC. US coverage today; UK · CA · AU expanding. Benchmark prices measure specific points in the supply chain - a benchmark, not a quote. Labeler names are as reported to FDA; name variants are merged into canonical entities (see methodology). Not medical advice. Join the waitlist for watchlists and supply alerts.

Mesalamine - manufacturers, supply & price · Pillstats

Drugs / Mesalamine

Rx only · Enema · Rectal

Mesalamine

2 ACTIVE SUPPLIERS - US

openFDA · updated weekly

US2 NDCs
2 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCA07EC02

RxCUI (US)52582

US makers2 labelers

Packages3

DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.

$0.125

Latest avg · Aug 19, 2026

-31%

Since Mar 19, 2025

Active US suppliers

100%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.

2.9K

Rx · 2026 Q1

4.5M

Units dispensed

+2%

Rx vs. year ago

Quarters · since 2024 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Padagis Israel Pharmaceuticals Ltd	generic	2	SUPPLYING
ANI Pharmaceuticals, Inc.	generic	1	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.

At a glance

FormEnema
RouteRectal
TypeRX
US NDCs2
Packages3
Labelers2

Watch this drug

Shortages, supplier exits, and recalls - in your account feed.

Monograph & sources

US prescribing informationDAILYMED
Price methodologySOON